News

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
And this time, it’s not just fringe actors fanning the flames. It’s policymakers. It’s media personalities. It’s individuals ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
The trial enrolled more than 40,800 adults 50 and older from 11 countries.
The preservative is in a small share of flu shots and has been studied for decades. Experts say it’s safe — despite Kennedy’s long opposition.
"This is a very clear effort to shine a light on this anti-vaccine trope: that thimerosal is somehow dangerous.” ...
Brewer was terminated by Health and Human Services Sec. Robert F. Kennedy Jr. from the vaccine advisory panel in June.
The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...
Oropouche virus disease was a relatively rare illness for decades, lurking on the margins of tropical rainforests in the Caribbean and South America. Sporadic reports of an infection causing fevers, ...
An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a ...
Colds and flu often cause sore throats that make swallowing and talking uncomfortable, while RSV in adults and older children usually mimics a mild cold. Cepacol® explores why sore throats are more ...